FdaApplication
NDA 209260
Identifiers
- fda_app_no: NDA209260
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2018-01-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATROPINE SULFATE | ATROPINE SULFATE | 8MG/20ML (0.4MG/ML) | SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL |
1 product